Clinical Trial

IH, Brain Health, and T2D

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to use a randomized, placebo-controlled study design to rigorously examine the therapeutic potential of intermittent hypoxia (IH) for improving cerebrovascular health in older adults with and without type 2 diabetes mellitus (T2DM).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-08; most recent amendment 2026-03-12.
Status change: Not Yet Recruiting → Recruiting 2025-09-19
Trial Details
NCT Number NCT07173543
Lead Sponsor Darren P Casey
Collaborators: American Diabetes Association
Conditions Type 2 Diabetes, Aging
Enrollment 80 participants
Start Date 2025-09-22
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-13